Skip to main content

Table 1 Baseline characteristics of patients with lung cancer

From: Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer

Variables

Total (N = 20,689),

n (%)

With cardiovascular disease (N = 6436),

n (%)

Without cardiovascular disease (N = 14,253),

n (%)

P-value

Age, in years

   

< 0.0001

 Mean (+STD)

69.5 (±11)

73.7 (±9.7)

67.6 (±11.1)

 

 Median (IQR)

70 (62–78)

75 (67–81)

68 (60–76)

 

Age group

   

< 0.0001

  < =60

4443 (21.5%)

658 (10.2%)

3785 (26.6%)

 

 61–70

6112 (29.5%)

1549 (24.1%)

4563 (32%)

 

 71–80

6717 (32.5%)

2590 (40.2%)

4127 (29%)

 

  > 80

3417 (16.5%)

1639 (25.5%)

1778 (12.5%)

 

Sex

   

< 0.0001

 Female

10,156 (49.1%)

2874 (44.7%)

7282 (51.1%)

 

 Male

10,533 (50.9%)

3562 (55.3%)

6971 (48.9%)

 

Year of diagnosis

   

0.0337

 2004–2009

9993 (48.3%)

3038 (47.2%)

6955 (48.8%)

 

 2010–2015

10,696 (51.7%)

3398 (52.8%)

7298 (51.2%)

 

CCI score

   

< 0.0001

 0

2566 (12.4%)

310 (4.8%)

2256 (15.8%)

 

 1

2614 (12.6%)

627 (9.7%)

1987 (13.9%)

 

  > 1

15,509 (75%)

5499 (85.4%)

10,010 (70.2%)

 

Histology

   

< 0.0001

 Adenocarcinoma

7727 (37.3%)

2024 (31.4%)

5703 (40%)

 

 SCC

3680 (17.8%)

1184 (18.4%)

2496 (17.5%)

 

 SCLC

2571 (12.4%)

799 (12.4%)

1772 (12.4%)

 

 Carcinoid/LCNE

520 (2.5%)

117 (1.8%)

403 (2.8%)

 

 Large cell cancer

260 (1.3%)

59 (0.9%)

201 (1.4%)

 

 Others

5931 (28.7%)

2253 (35%)

3678 (25.8%)

 

Stage

 I

3636 (17.6%)

1127 (17.5%)

2509 (17.6%)

< 0.0001

 II

880 (4.3%)

250 (3.9%)

630 (4.4%)

 

 III

5168 (25%)

1591 (24.7%)

3577 (25.1%)

 

 IV

10,409 (50.3%)

3207 (49.8%)

7202 (50.5%)

 

 Unknown

596 (2.9%)

261 (4.1%)

335 (2.4%)

 

T stage

 T0

110 (0.5%)

44 (0.7%)

66 (0.5%)

< 0.0001

 T1

3095 (15%)

985 (15.3%)

2110 (14.8%)

 

 T2

6581 (31.8%)

2001 (31.1%)

4580 (32.1%)

 

 T3

788 (3.8%)

188 (2.9%)

600 (4.2%)

 

 T4

9378 (45.3%)

2966 (46.1%)

6412 (45%)

 

 Unknown

737 (3.6%)

252 (3.9%)

485 (3.4%)

 

N stage

 N0

6540 (31.6%)

2126 (33%)

4414 (31%)

< 0.0001

 N1

1729 (8.4%)

494 (7.7%)

1235 (8.7%)

 

 N2

7453 (36%)

2302 (35.8%)

5151 (36.1%)

 

 N3

3803 (18.4%)

1073 (16.7%)

2730 (19.2%)

 

 Unknown

1164 (5.6%)

441 (6.9%)

723 (5.1%)

 

M stage

 M0

9877 (47.7%)

3069 (47.7%)

6808 (47.8%)

0.0008

 M1

10,409 (50.3%)

3207 (49.8%)

7202 (50.5%)

 

 Unknown

403 (1.9%)

160 (2.5%)

243 (1.7%)

 

Laterality

 Bilateral

211 (1%)

74 (1.1%)

137 (1%)

0.0003

 Left

8477 (41%)

2677 (41.6%)

5800 (40.7%)

 

 Right

11,568 (55.9%)

3515 (54.6%)

8053 (56.5%)

 

 Unknown

433 (2.1%)

170 (2.6%)

263 (1.8%)

 

Surgery

 No

17,274 (83.5%)

5721 (88.9%)

11,553 (81.1%)

< 0.0001

 Lobectomy or segmental

3168 (15.3%)

686 (10.7%)

2482 (17.4%)

 

 Pneumonectomy

247 (1.2%)

29 (0.5%)

218 (1.5%)

 

Chemotherapy

 No

15,029 (72.6%)

5378 (83.6%)

9651 (67.7%)

< 0.0001

 Yes

5660 (27.4%)

1058 (16.4%)

4602 (32.3%)

 

Immunotherapy

 No

20,669 (99.9%)

6433 (100%)

14,236 (99.9%)

0.1195

 Yes

20 (0.1%)

3 (0%)

17 (0.1%)

 

Radiation

 No

14,418 (69.7%)

4743 (73.7%)

9675 (67.9%)

< 0.0001

 Yes

6271 (30.3%)

1693 (26.3%)

4578 (32.1%)

 

Institution type

 Academic

10,713 (51.8%)

3119 (48.5%)

7594 (53.3%)

< 0.0001

 Community

9976 (48.2%)

3317 (51.5%)

6659 (46.7%)

 

Driving time (hours)

 1

15,419 (74.5%)

4704 (73.1%)

10,715 (75.2%)

< 0.0001

 2

2885 (13.9%)

1010 (15.7%)

1875 (13.2%)

 

  > 2

2385 (11.5%)

722 (11.2%)

1663 (11.7%)

 

Health Zone

 Calgary

6192 (29.9%)

1781 (27.7%)

4411 (30.9%)

< 0.0001

 Central

3125 (15.1%)

1045 (16.2%)

2080 (14.6%)

 

 Edmonton

7159 (34.6%)

2239 (34.8%)

4920 (34.5%)

 

 North

2459 (11.9%)

755 (11.7%)

1704 (12%)

 

 South

1754 (8.5%)

616 (9.6%)

1138 (8%)

 

Educational levela

  < = 80%

10,133 (49%)

3281 (51%)

6852 (48.1%)

0.0005

  > 80%

10,527 (50.9%)

3147 (48.9%)

7380 (51.8%)

 

 Unknown

29 (0.1%)

8 (0.1%)

21 (0.1%)

 

Income level

  < = 46 k

12,849 (62.1%)

4085 (63.5%)

8764 (61.5%)

0.0237

  > 46 k

7811 (37.8%)

2343 (36.4%)

5468 (38.4%)

 

 Unknown

29 (0.1%)

8 (0.1%)

21 (0.1%)

 
  1. STD Standard deviation, IQR Interquartile range, CCI Charlson’s comorbidity index, SCC Squamous cell cancer, SCLC Small cell lung cancer, LCNE Large Cell Neuroendocrine tumor. a80% of residents have high school and above level of education in the neighborhood